PHARMADAN A/S: Financial statements 2021
CVR: 26524938
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
PHARMADAN A/S (CVR 26524938) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -2,844,193 and a net result of DKK -2,511,252 compared with DKK -1,618,210 the year before. Equity in the 2021 report amounted to DKK -1,494,318.
- Gross Profit
- DKK -2,844,193
- Profit/Loss
- DKK -2,511,252
- Equity
- DKK -1,494,318
- Total Assets
- DKK 3,113,287
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -2.8M | -2.5M | -1.5M | - |
| 2020 | - | -8K | -1.6M | 1M | 3 |
| 2019 | - | 956K | -800K | 2.6M | 3 |
| 2018 | - | 973K | -1.6M | 3.4M | 4 |
| 2017 | - | 585K | -2.6M | -919K | 5 |
Official annual report
Find more companies like PHARMADAN A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout PHARMADAN A/S
PHARMADAN A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 2002. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Peter Rørvig. The board consists of Helle Rørvig, Niels Ulrik Heine and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,382,654 and a net result of DKK -5,426,641 compared with DKK -5,113,611 the year before. Equity in the 2025 report amounted to DKK -18,955,125.